Composition:
Each gram of Fusibact B cream contains, Fusidic acid 20 mg and Betamethasone valerate 1.0 mg in suitable cream base.
Indications:
FUSIBACT B Cream is indicated for: Fusibact B is indicated in treatment of Inflammatory dermatoses where bacterial infection is present or likely to occur. Inflammatory dermatoses include atopic eczema, discoid eczema, stasis eczema, seborrhoeic dermatitis, contact dermatitis, lichen simplex chronicus, psoriasis, discoid lupus erythematosus.
Presentation:
Fusibact B cream, 15 gm in Aluminium collapsible tube.